Bristol-Myers Squibb Company (NYSE:BMY) has been ranked No. 1 on Corporate Responsibility magazine's 2014 list of the 100 Best Corporate Citizens, a leading benchmark for socially responsible investors and other stakeholders. Bristol-Myers Squibb is the only company to achieve the No. 1 ranking three times, including 2009 and 2012, and has ranked among the top 10 each of the last six years.
The 100 Best Corporate Citizens list ranks companies in the Russell 1000 using nearly 300 data points in seven categories: environment, climate change, employee relations, human rights, governance, finance, and philanthropy.
"We are proud to again be recognized for our commitment to social responsibility and corporate citizenship," said Lamberto Andreotti, chief executive officer, Bristol-Myers Squibb. "Our efforts to promote economic, social and environmental sustainability are core to our company's mission and reflect our ongoing commitment to patients, our employees and partners, the environment, and communities around the world."
Investors, customers, suppliers, regulators, employees and other stakeholders use the list to assess how well publicly traded companies hold themselves accountable in these seven important categories while also enabling shareholders and other stakeholders to make more informed decisions.
"At Bristol-Myers Squibb, the principles that make us a top corporate citizen are well established in the company's culture and values," said Susan Voigt, vice president, Environment, Health, Safety and Sustainability. "Our employees are deeply involved in many social responsibility initiatives and committed to conducting our business in an ethical and sustainable manner."
Bristol-Myers Squibb's commitment to sustainable, ethical and compliant global business practices serves as the foundation of the company's Sustainability 2015 goals, which continue to build upon the accomplishments of previous Sustainability goals.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global specialty care biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.